SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-015420
Filing Date
2019-03-22
Accepted
2019-03-22 07:00:14
Documents
5
Period of Report
2019-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv516899_8k.htm 8-K 29258
2 EXHIBIT 2.1 tv516899_ex2-1.htm EX-2.1 674087
3 EXHIBIT 10.1 tv516899_ex10-1.htm EX-10.1 173316
4 EXHIBIT 99.1 tv516899_ex99-1.htm EX-99.1 27385
5 GRAPHIC tv516899_ex99-1img01.jpg GRAPHIC 19870
  Complete submission text file 0001144204-19-015420.txt   932886
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 19698367
SIC: 8731 Services-Commercial Physical & Biological Research